Update on results and complications of cyclophotocoagulation

Current Opinion in Ophthalmology

Volumn 24, Issue 2, 2013, Pages 102-110

  Ishida, Kyoko ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclophotocoagulation; Diode Laser; Endoscopic Cyclophotocoagulation; Glaucoma; Transscleral Cyclophotocoagulation

Indexed keywords

ATONIC PUPIL; CATARACT; CHOROID HEMORRHAGE; CLOSED ANGLE GLAUCOMA; ENDOPHTHALMITIS; ENDOSCOPIC DIODE CYCLOPHOTOCOAGULATION; EYE BURN; HUMAN; HYPHEMA; KERATOPATHY; LASER COAGULATION; LENS SUBLUXATION; LUNG TUBERCULOSIS; MALIGNANT GLAUCOMA; MUSCLE HYPOTONIA; NECROTIZING SCLERITIS; NEOVASCULAR GLAUCOMA; OPEN ANGLE GLAUCOMA; PIGMENT DISORDER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; REVIEW; SECONDARY GLAUCOMA; SYMPATHETIC OPHTHALMIA; TRANSIENT PUPIL OVALIZATION; TRANSSCLERAL CYCLOPHOTOCOAGULATION; UVEITIS; VISUAL IMPAIRMENT; VITREORETINAL SURGERY; VITREOUS HEMORRHAGE;

CILIARY BODY; ENDOSCOPY; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LASER COAGULATION; LASERS, SEMICONDUCTOR; OPHTHALMOLOGIC SURGICAL PROCEDURES; SCLERA;

EID: 84876294117     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32835d9335     Document Type: Review

References (81)

1. Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol 2001; 119:345-350.
2. Gupta V, Agarwal HC. Contact trans-scleral diode laser cyclophotocoagulation treatment for refractory glaucomas in the Indian population. Indian J Ophthalmol 2000; 48:295-300.
3. Ramli N, Htoon HM, Ho CL, et al. Risk factors for hypotony after transscleral diode cyclophotocoagulation. J Glaucoma 2012; 21:169-173. This study evaluated risk factors associated with hypotony after TCP in 90 eyes with intractable glaucoma and detected underlying diagnosis of NVG as a significant risk factor for hypotony.
4. Lai JS, Tham CC, Chan JC, Lam DS. Diode laser transscleral cyclophotocoagulation as primary surgical treatment for medically uncontrolled chronic angle closure glaucoma: long-term clinical outcomes. J Glaucoma 2005; 14:114-119.
5. Hauber FA, Scherer WJ. Influence of total energy delivery on success rate after contact diode laser transscleral cyclophotocoagulation: a retrospective case review and meta-analysis. J Glaucoma 2002; 11:329-333.
6. Noureddin BN, Zein W, Haddad C, et al. Diode laser transscleral cyclophotocoagulation for refractory glaucoma: a 1 year follow-up of patients treated using an aggressive protocol. Eye 2006; 20:329-335.
7. Murphy CC, Burnett CA, Spry PG, et al. A two centre study of the doseresponse relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2003; 87:1252-1257.
8. Mistlberger A, Liebmann JM, Tschiderer H, et al. Diode laser transscleral cyclophotocoagulation for refractory glaucoma. J Glaucoma 2001; 10:288-293.
9. Frezzotti P, Mittica V, Martone G, et al. Long-term follow-up of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Acta Ophthalmol 2010; 88:150-155.
10. Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2007; 91:1631-1635.
11. Schlote T, Derse M, Rassmann K, et al. Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma 2001; 10:294-301.
12. Kramp K, Vick HP, Guthoff R. Transscleral diode laser contact cyclophotocoagulation in the treatment of different glaucomas, also as primary surgery. Graefes Arch Clin Exp Ophthalmol 2002; 240:698-703.
13. Leszczyń ski R, Gierek-Lapiń ska A, Formin'ska-Kapuś cik M. Transscleral cyclophotocoagulation in the treatment of secondary glaucoma. Med Sci Monit 2004; 10:CR542-CR548.
14. Grueb M, Rohrbach JM, Bartz-Schmidt KU, Schlote T. Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliative glaucoma. Long-term clinical outcomes. Graefes Arch Clin Exp Ophthalmol 2006; 244:1293-1299.
15. Kaushik S, Pandav SS, Jain R, et al. Lower energy levels adequate for effective transscleral diode laser cyclophotocoagulation in Asian eyes with refractory glaucoma. Eye 2008; 22:398-405.
16. Osman EA, Al-Muammar A, Mousa A, et al. Controlled cyclophotocoagulation with diode laser in refractory glaucoma and long term follow up at King Abdulaziz University Hospital, Riyadh. Saudi J Ophthalmol 2010; 24:9-13.
17. Goldenberg-Cohen N, Bahar I, Ostashinski M, et al. Cyclocryotherapy versus transscleral diode laser cyclophotocoagulation for uncontrolled intraocular pressure. Ophthalmic Surg Lasers Imaging 2005; 36:272-279.
18. Pucci V, Tappainer F, Borin S, Bellucci R. Long-term follow-up after transscleral diode laser photocoagulation in refractory glaucoma. Ophthalmologica 2003; 217:279-283.
19. Vernon SA, Koppens JM, Menon GJ, Negi AK. Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature. Clin Exp Ophthalmol 2006; 34:411-420.
20. Nabili S, Kirkness CM. Trans-scleral diode laser cyclophoto-coagulation in the treatment of diabetic neovascular glaucoma. Eye 2004; 18:352-356.
21. Ansari E, Gandhewar J. Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and nonrefractory glaucoma. Eye 2007; 21:936-940.
22. Rotchford AP, Jayasawal R, Madhusudhan S, et al. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol 2010; 94:1180-1183.
23. Huang G, Lin SC. When should we give up filtration surgery: indications, techniques and results of cyclodestruction. Dev Ophthalmol 2012; 50:173-183. Excellent review of the indications, techniques, and results of cyclodestruction.
24. Tzamalis A, Pham DT, Wirbelauer C. Diode laser cyclophotocoagulation versus cyclocryotherapy in the treatment of refractory glaucoma. Eur J Ophthalmol 2011; 21:589-596.
25. McKelvie PA, Walland MJ. Pathology of cyclodiode laser: a series of nine enucleated eyes. Br J Ophthalmol 2002; 86:381-386.
26. Schuman JS, Noecker RJ, Puliafito CA, et al. Energy levels and probe placement in contact transscleral semiconductor diode laser cyclophotocoagulation in human cadaver eyes. Arch Ophthalmol 1991; 109:1534-1538.
27. Stroman GA, Stewart WC, Hamzavi S, et al. Contact versus noncontact diode laser transscleral cyclophotocoagulation in cadaver eyes. Ophthalmic Surg Lasers 1996; 27:60-65.
28. Schlote T, Grǔb M, Kynigopoulos M. Long-term results after transscleral diode laser cyclophotocoagulation in refractory posttraumatic glaucoma and glaucoma in aphakia. Graefes Arch Clin Exp Ophthalmol 2008; 246:405-510.
29. Zhang SH, Dong FT, Mao J, Bian AL. Factors related to prognosis of refractory glaucoma with diode laser transscleral cyclophotocoagulation treatment. Chin Med Sci J 2011; 26:137-140.
30. Kirwan JF, Shah P, Khaw PT. Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas. Ophthalmology 2002; 109:316-323.
31. Autrata R, Rehurek J. Long-term results of transscleral cyclophotocoagulation in refractory pediatric glaucoma patients. Ophthalmologica 2003; 217:393-400.
32. Kumar A, Dada T, Singh RP, Kedar S. Diode laser trans-scleral cyclophotocoagulation for glaucoma following silicone oil removal. Clin Exp Ophthalmol 2001; 29:220-224.
33. Schlote T, Derse M, Zierhut M. Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases. Br J Ophthalmol 2000; 84:999-1003.
34. Fankhauser F, Kwasniewska S, Van der Zypen E. Cyclodestructive procedures. I. Clinical and morphological aspects: a review. Ophthalmologica 2004; 218:77-95.
35. Manna A, Foster P, Papadopoulos M, Nolan W. Cyclodiode laser in the treatment of acute angle closure. Eye 2012; 26:742-745.
36. Preussner PR, Ngounou F, Kouogan G. Controlled cyclophotocoagulation with the 940 nm laser for primary open angle glaucoma in African eyes. Graefes Arch Clin Exp Ophthalmol 2010; 248:1473-1479.
37. Chang SH, Chen YC, Li CY, Wu SC. Contact diode laser transscleral cyclophotocoagulation for refractory glaucoma: comparison of two treatment protocols. Can J Ophthalmol 2004; 39:511-516.
38. Izgi B, Demirci H, Demirci FY, Turker G. Diode laser cyclophotocoagulation in refractory glaucoma: comparison between pediatric and adult glaucomas. Ophthalmic Surg Lasers 2001; 32:100-107.
39. Sood S, Beck AD. Cyclophotocoagulation versus sequential tube shunt as a secondary intervention following primary tube shunt failure in pediatric glaucoma. J AAPOS 2009; 13:379-383.
40. Semchyshyn TM, Tsai JC, Joos KM. Supplemental transscleral diode laser cyclophotocoagulation after aqueous shunt placement in refractory glaucoma. Ophthalmology 2002; 109:1078-8104.
41. Ness PJ, Khaimi MA, Feldman RM, et al. Intermediate term safety and efficacy of transscleral cyclophotocoagulation after tube shunt failure. J Glaucoma 2012; 21:83-88.
42. Yildirim N, Yalvac IS, Sahin A, et al. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. J Glaucoma 2009; 18:192-196.
43. Walland MJ. Diode laser cyclophotocoagulation: longer term follow up of a standardized treatment protocol. Clin Exp Ophthalmol 2000; 28:263-267.
44. Martin KR, Broadway DC. Cyclodiode laser therapy for painful, blind glaucomatous eyes. Br J Ophthalmol 2001; 85:474-476.
45. Ghosh S, Singh D, Ruddle JB, et al. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Experiment Ophthalmol 2010; 38:353-377.
46. Fong AW, Lee GA, O'Rourke P, Thomas R. Management of neovascular glaucomawith transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Clin Experiment Ophthalmol 2011; 39:318-323.
47. Contreras I, Noval S, Gonzá lez Martín-Moro J, et al. IOP spikes following contact transscleral diode laser cyclophotocoagulation. Arch Soc Esp Oftalmol 2004; 79:105-109.
48. Hossain P, Ghosh G, Vernon SA. Assessing the 'cyclodiode G-probe' using a grey scale test: reproducibility and differences between probes. Eye 2003; 17:167-176.
49. Rao VJ, Dayan M. Lens subluxation following contact transscleral cyclodiode. Arch Ophthalmol 2002; 120:1393-1394.
50. Muqit MM, Menage MJ. Malignant glaucoma after phacoemulsification: treatment with diode laser cyclophotocoagulation. J Cataract Refract Surg 2007; 33:130-132.
51. Shen SY, Lai JS, LamDS. Necrotizing scleritis following diode laser transscleral cyclophotocoagulation. Ophthalmic Surg Lasers Imaging 2004; 35:251-253.
52. Kumar N, Chang A, Beaumont P. Sympathetic ophthalmia following ciliary body laser cyclophotocoagulation for rubeotic glaucoma. Clin Exp Ophthalmol 2004; 32:196-198.
53. Pokroy R, Greenwald Y, Pollack A, et al. Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2008; 39:22-29.
54. Shah P, Lee GA, Kirwan JK, et al. Cyclodiode photocoagulation for refractory glaucoma after penetrating keratoplasty. Ophthalmology 2001; 108:1986-1991.
55. Ocakoglu O, Arslan OS, Kayiran A. Diode laser transscleral cyclophotocoagulation for the treatment of refractory glaucoma after penetrating keratoplasty. Curr Eye Res 2005; 30:569-574.
56. Wilensky JT, Kammer J. Long-term visual outcome of transscleral laser cyclotherapy in eyes with ambulatory vision. Ophthalmology 2004; 111:1389-1392.
57. Agrawal P, Dulku S, Nolan W, Sung V. The UK National Cyclodiode Laser Survey. Eye 2011; 25:168-173.
58. Chen J, Cohn RA, Lin SC, et al. Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol 1997; 124:787-796.
59. Murthy GJ, Murthy PR, Murthy KR, et al. A study of the efficacy of endoscopic cyclophotocoagulation for the treatment of refractory glaucomas. Indian J Ophthalmol 2009; 57:127-132.
60. Yu MB, Huang SS, Ge J, et al. The clinical study of endoscopic cyclophotocoagulation on the management of refractory glaucoma. Zhonghua Yan Ke Za Zhi 2006; 42:27-31.
61. Al-Haddad CE, Freedman SF. Endoscopic laser cyclophotocoagulation in pediatric glaucoma with corneal opacities. J AAPOS 2007; 11:23-28.
62. Lee RM, Al Raqqad N, Gomaa A, et al. Endoscopic cyclophotocoagulation in osteo-odonto-keratoprosthesis (OOKP) eyes. J Glaucoma 2011; 20:68-69.
63. Barkana Y, Morad Y, Ben-nun J. Endoscopic photocoagulation of the ciliary body after repeated failure of trans-scleral diode-laser cyclophotocoagulation. Am J Ophthalmol 2002; 133:405-407.
64. Neely DE, Plager DA. Endocyclophotocoagulation for management of difficult pediatric glaucomas. J AAPOS 2001; 5:221-229.
65. Carter BC, Plager DA, Neely DE, et al. Endoscopic diode laser cyclophotocoagulation in the management of aphakic and pseudophakic glaucoma in children. J AAPOS 2007; 11:34-40.
66. Plager DA, Neely DE. Intermediate-term results of endoscopic diode laser cyclophotocoagulation for pediatric glaucoma. J AAPOS 1999; 3:131-137.
67. Lin SC. Endoscopic and transscleral cyclophotocoagulation for the treatment of refractory glaucoma. J Glaucoma 2008; 17:238-247.
68. Francis BA, Kawji AS, Vo NT, et al. Endoscopic cyclophotocoagulation (ECP) in the management of uncontrolled glaucoma with prior aqueous tube shunt. J Glaucoma 2011; 20:523-527.
69. Lima FE, Magacho L, Carvalho DM, et al. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma 2004; 13:233-237.
70. Lindfield D, Ritchie RW, Griffiths MF. 'Phaco-ECP': combined endoscopic cyclophotocoagulation and cataract surgery to augment medical control of glaucoma. BMJ Open 2012; 2:1-6. The authors reviewed 58 cases treated with phaco-ECP and proposed the role of the phaco-ECP in management of glaucoma.
71. Kahook MY, Lathrop KL, Noecker RJ. One-site versus two-site endoscopic cyclophotocoagulation. J Glaucoma 2007; 16:527-530.
72. Barke SJ, Sturm RT, Caronia RM, et al. Phacoemulsification combined with endoscopic cyclophotocoagulation (ECP) in the management of cataract and medically controlled glaucoma: A large, long term study. In: American Glaucoma Society 16th Annual Meeting; 2-5 March 2006; Charleston, SC; 2006. Abstract 22:47.
73. Lima FE, Carvalho DM, Avila MP. Phacoemulsification and endoscopic cyclophotocoagulation as primary surgical procedure in coexisting cataract and glaucoma]. Arq Bras Oftalmol 2010; 73:419-422.
74. Gayton JL, Van Der Karr M, Sanders V. Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation. J Cataract Refract Surg 1999; 25:1214-1219.
75. The ECP Collaborative Study Group. Complications of ECP: a large, long term, multicenter study. Ocul Surg News. February 2006.
76. The ECP Study Group. Comparison of phaco/ECP to phaco alone in 1000 glaucoma patients; a randomized, prospective including fluorescein angiography in all patients in both groups. Presented at the ASCRS; June 2002; Philadelphia, PA.
77. Berke SJ. Endolaser Cyclophotocoagulation in glaucoma management. Tech Ophthalmol 2006; 4:74-81.
78. Yip LW, Yong SO, Earnest A, et al. Endoscopic cyclophotocoagulation for the treatment of glaucoma: an Asian experience. Clin Exp Ophthalmol 2009; 37:692-697.
79. Pantcheva MB, Kahook MY, Schuman JS, Noecker RJ. Comparison of acute structural and histopathological changes in human autopsy eyes after endoscopic cyclophotocoagulation and trans-scleral cyclophotocoagulation. Br J Ophthalmol 2007; 91:248-252.
80. Pantcheva MB, Kahook MY, Schuman JS, et al. Comparison of acute structural and histopathological changes of the porcine ciliary processes after endoscopic cyclophotocoagulation and transscleral cyclophotocoagulation. Clin Experiment Ophthalmol 2007; 35:270-274.
81. Lin SC, Chen MJ, Lin MS, et al. Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation. Br J Ophthalmol 2006; 90:496-500.